Archives
-
Lypressin acetate: Assay Workflows & Use Cases
2026-09-04
Lypressin acetate connects vasopressin-receptor biology with practical antidiuretic, vascular, and exploratory antiviral workflows. This guide shows how to handle Lysine vasopressin acetate, build concentration-response assays, compare readouts, and troubleshoot peptide-specific variability.
-
POx-Lipid LNPs as PEG Alternatives for mRNA Delivery
2026-09-04
Holick and colleagues investigate poly(2-ethyl-2-oxazoline)-lipids as substitutes for PEG-lipids in mRNA lipid nanoparticles, linking polymer chain length with particle properties, immune response, transfection, and cellular uptake. Their combined formulation and super-resolution microscopy strategy identified a PEtOx-LNP that outperformed the commercial PEG-lipid comparator used in Comirnaty, while also clarifying why polymer architecture matters for nucleic-acid delivery.
-
IRG1–Itaconic Acid Control of TBK1 and Type I IFN
2026-09-03
Chai et al. identify an IRG1–itaconic acid feedback mechanism that restrains excessive type I interferon signaling by alkylating TBK1 at Cys605 and disrupting TBK1 dimerization. The study also introduces ITA-5 and ITA-9 as itaconic acid-based inhibitors, providing a mechanistic framework for studying metabolism-driven control of antiviral inflammation.
-
Caged Bioluminescent Probes for the Immunoproteasome
2026-09-03
The reference protocol presents a cleavable, aminoluciferin-based activity probe designed to report β5i immunoproteasome activity with a luminescent plate-reader assay. Its main contribution is a practical synthesis and testing workflow that connects isoform-selective peptide recognition with a reporter format potentially suited to live-cell and tissue-mimic experiments, while leaving in vivo validation for future work.
-
HBTU Workflow for Responsive Peptide Synthesis
2026-09-02
HBTU streamlines carboxylic acid activation and peptide bond formation for demanding solid phase peptide synthesis, including enzyme-responsive peptide amphiphiles. This practical guide connects coupling control, analytical checkpoints, and troubleshooting with the dual-enzyme cancer-selectivity strategy reported in a 2026 Biomacromolecules study.
-
ETS1–SENP2 Signaling in Bronchopulmonary Dysplasia
2026-09-02
The reference study identifies ETS1 as a transcriptional regulator of mitochondrial quality control in hyperoxia-associated bronchopulmonary dysplasia. Its central mechanistic advance is the connection of ETS1-driven SENP2 expression with FUNDC1 deSUMOylation, HSPA8 binding, and suppression of excessive mitophagy, although several model details and one internally inconsistent abstract statement require verification in the full paper.
-
EDC.HCl: In Vitro Coupling Guide
2026-09-01
EDC.HCl is a water-soluble carbodiimide that helps activate carboxyl groups for amide bond formation with primary amines in peptide synthesis and bioconjugation workflows. It is intended for controlled in vitro laboratory use; the dossier provides no in vivo or clinical data.
-
HotStart Universal 2X Green qPCR Master Mix Workflow
2026-09-01
Build reproducible dye-based qPCR assays around the seven-gene hepatocellular carcinoma signature reported in a large multi-center study. This practical guide connects assay design, melt curve quality control, ROX normalization, and troubleshooting for translational gene expression workflows.
-
Cell Counting Kit-8 Plus in CRC Research
2026-08-31
Cell Counting Kit-8 Plus provides a rapid WST-8 readout for connecting colorectal cancer cell growth with ferroptosis-focused experiments. This practical guide translates the SLC11A1–TGF-β1 findings into plate-based workflows, assay controls, and troubleshooting strategies for proliferation, cytotoxicity, and drug-response studies.
-
HotStart 2X Green qPCR Master Mix for TRIB3
2026-08-31
Translate TRIB3 ferroptosis biology into a controlled, SYBR Green workflow for gene expression, treatment-response studies, and RNA-seq validation. This practical guide pairs hot-start specificity with assay design, quantified QC checkpoints, and troubleshooting for clear cell renal cell carcinoma experiments.
-
GPC3-HSP70 mRNA Nanovaccine in HCC
2026-08-30
Wang and colleagues developed an mRNA nanovaccine encoding three GPC3127–136 cytotoxic T-lymphocyte epitopes fused to HSP70 and delivered with the tumor-targeting peptide SP94-GGG-K18. In the reported HCC models, vaccination increased antigen-specific CD8+ T-cell responses, while combination with anti-PD-L1 therapy produced stronger antitumor activity than either strategy alone.
-
Cabazitaxel (XRP6258): Practical Protocol Guide
2026-08-29
Cabazitaxel (XRP6258, SKU B2157) is a semi-synthetic taxane derivative for investigating microtubule dynamics disruption, including studies of P-glycoprotein-expressing and taxane-resistant cancer models. It is suitable for DMSO- or ethanol-based workflows but is insoluble in water, and prepared solutions should be used promptly rather than stored long term.
-
ApexPrep DNA Plasmid Miniprep Kit for AML
2026-08-28
The ApexPrep DNA Plasmid Miniprep Kit uses alkaline lysis and membrane adsorption to produce molecular biology grade plasmid DNA from bacterial cultures. Its stated capacity is up to 30 μg per preparation from 1–5 mL of culture, supporting cloning, sequencing, transformation, and transfection workflows.
-
Dinaciclib (SCH727965) for Reliable Cell Assays
2026-08-28
Learn how Dinaciclib (SCH727965), SKU A8412, can support reproducible cell-cycle, viability, and apoptosis experiments through mechanism-aware controls and practical handling. The article connects CDK inhibition with assay interpretation while distinguishing product-documented evidence from workflow recommendations.
-
Haptotactic Motion of Multivalent Vesicles: Study Insights
2026-08-27
Sleath and colleagues combine experiments, numerical simulations, and theory to show that multivalent vesicles can drift toward higher ligand densities without an active motility program. Their results identify binding strength and vesicle size as key variables for designing passive, biomimetic haptotactic systems.